AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Revised PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodin, G. S.
Right arrow Articles by McCarville, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodin, G. S.
Right arrow Articles by McCarville, M. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.06.0171
AJR 2006; 187:1124-1128
© American Roentgen Ray Society


Clinical Observations

PET/CT Characterization of Fibroosseous Defects in Children: 18F-FDG Uptake Can Mimic Metastatic Disease

Geoffrey S. Goodin1,2, Barry L. Shulkin1, Robert A. Kaufman1,2,3 and M. Beth McCarville1,2

1 Division of Diagnostic Imaging, Department of Radiological Sciences, MS 210, St. Jude Children's Research Hospital, 332 N Lauderdale St., Memphis, TN 38105-2794.
2 Department of Radiology, University of Tennessee Health Science Center, Memphis, TN 38163.
3 Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38163.

OBJECTIVE. The purpose of this study was to characterize the anatomic appearance and metabolic activity of nonossifying fibromas, fibrous cortical defects, and cortical desmoids on PET/CT images.

CONCLUSION. Over a 14-month period, we identified eight nonossifying fibromas, four fibrous cortical defects, and two cortical desmoids in 330 children who underwent PET/CT for the evaluation of a known or suspected malignancy. CT, conventional radiography, MRI, or clinical follow-up was used to confirm the diagnoses of these fibroosseous lesions. Eleven of the 14 children underwent multiple PET/CT examinations; thus, 34 studies were included. The lesions showed variable metabolic activity as indicated by 18F-FDG uptake: 19 PET/CT examinations showed lesions with mild 18F-FDG uptake, eight showed moderate 18F-FDG uptake, and seven showed intense uptake. When PET reveals metabolically active osseous abnormalities in children who are at risk for bone metastases, benign fibroosseous lesions should be considered in the differential diagnosis before additional diagnostic procedures are undertaken. Benign fibroosseous lesions may be metabolically active and thus mimic metastatic osseous disease in children with underlying malignancies. Correlative CT or other anatomic imaging can confirm the benign nature of these lesions.

Keywords: cortical desmoid • fibroosseous defects • fibrous cortical defect • nonossifying fibroma • nuclear imaging • pediatric imaging • PET/CT


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
The OncologistHome page
J. Landa and L. H. Schwartz
Contemporary Imaging in Sarcoma
Oncologist, October 1, 2009; 14(10): 1021 - 1038.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
A. Shammas, R. Lim, and M. Charron
Pediatric FDG PET/CT: Physiologic Uptake, Normal Variants, and Benign Conditions
RadioGraphics, September 1, 2009; 29(5): 1467 - 1486.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
J. M. Bestic, J. J. Peterson, and L. W. Bancroft
Use of FDG PET in Staging, Restaging, and Assessment of Therapy Response in Ewing Sarcoma
RadioGraphics, September 1, 2009; 29(5): 1487 - 1500.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.